Xiaobi Guo1, Jianzhang Feng, Hengshan Guo. 1. Department of Cardiology, Guangzhou Red Cross Hospital, The Fourth Affiliated Hospital of Medical College of Jinan University;
Abstract
BACKGROUND: The evaluation of patients with acute chest pain is time consuming and complicated. In the present study, the role of the bedside troponin T (TnT) test was prospectively investigated for predicting the risk of death and acute heart failure (AHF) in patients with acute chest pain. METHODS: Five hundred two consecutive patients admitted in the 24 h after the onset of chest pain were enrolled in the study. Tests of bedside TnT, qualitative troponin I, myoglobin, creatine kinase and creatine kinase (muscle-brain), and electrocardiography were performed on these patients. RESULTS: For the bedside TnT test, 160 (31.9%) patients had positive results and 323 (64.3%) patients had negative results. During 30 days of follow-up, the differences between TnT-positive and TnT-negative patients were as follows: 139 (86.9%) positive patients and seven (2.2%) negative patients were diagnosed with acute myocardial infarction (AMI) (OR=298.8 for AMI in positive versus negative patients); 51 (31.9%) positive patients and 37 (11.5%) negative patients had AHF (OR=3.6 for AHF in positive versus negative patients); 39 (24.4%) positive patients and 15 (4.6%) negative patients died (OR=6.7 for all-cause death in positive versus negative patients); 31 (19.4%) positive patients and five (1.5%) negative patients died due to a cardiac event (OR=15.8 for cardiac death in positive versus negative patients). The sensitivity and specificity of the bedside TnT test for diagnosing AMI were 95.2% and 93.8%, respectively. CONCLUSIONS: The bedside TnT test is a powerful, independent and valuable tool for risk stratification in patients with acute chest pain.
BACKGROUND: The evaluation of patients with acute chest pain is time consuming and complicated. In the present study, the role of the bedside troponin T (TnT) test was prospectively investigated for predicting the risk of death and acute heart failure (AHF) in patients with acute chest pain. METHODS: Five hundred two consecutive patients admitted in the 24 h after the onset of chest pain were enrolled in the study. Tests of bedside TnT, qualitative troponin I, myoglobin, creatine kinase and creatine kinase (muscle-brain), and electrocardiography were performed on these patients. RESULTS: For the bedside TnT test, 160 (31.9%) patients had positive results and 323 (64.3%) patients had negative results. During 30 days of follow-up, the differences between TnT-positive and TnT-negative patients were as follows: 139 (86.9%) positive patients and seven (2.2%) negative patients were diagnosed with acute myocardial infarction (AMI) (OR=298.8 for AMI in positive versus negative patients); 51 (31.9%) positive patients and 37 (11.5%) negative patients had AHF (OR=3.6 for AHF in positive versus negative patients); 39 (24.4%) positive patients and 15 (4.6%) negative patients died (OR=6.7 for all-cause death in positive versus negative patients); 31 (19.4%) positive patients and five (1.5%) negative patients died due to a cardiac event (OR=15.8 for cardiac death in positive versus negative patients). The sensitivity and specificity of the bedside TnT test for diagnosing AMI were 95.2% and 93.8%, respectively. CONCLUSIONS: The bedside TnT test is a powerful, independent and valuable tool for risk stratification in patients with acute chest pain.
Authors: M M Hirschl; H Herkner; A N Laggner; C Sylvén; G Rasmanis; P O Collinson; W Gerhardt; R Leinberger; R Zerback; M Müller-Bardorff; H A Katus Journal: Arch Pathol Lab Med Date: 2000-04 Impact factor: 5.534
Authors: R T van Domburg; C Cobbaert; M Müller-Bardorff; M Kampmann; G P Kimman; T Rauscher; S Schoolmann; R Zerback; H A Katus; M L Simoons Journal: Scand J Clin Lab Invest Date: 2000-12 Impact factor: 1.713
Authors: E M Ohman; P W Armstrong; R H Christenson; C B Granger; H A Katus; C W Hamm; M A O'Hanesian; G S Wagner; N S Kleiman; F E Harrell; R M Califf; E J Topol Journal: N Engl J Med Date: 1996-10-31 Impact factor: 91.245
Authors: Lijuan Zhan; Frederick A Masoudi; Xi Li; Shuang Hu; Arjun K Venkatesh; John A Spertus; Zhenqiu Lin; Nihar R Desai; Jing Li; Harlan M Krumholz; Lixin Jiang Journal: PLoS One Date: 2015-04-20 Impact factor: 3.240
Authors: Christoph Gräni; Oliver Senn; Manuel Bischof; Pietro E Cippà; Till Hauffe; Lukas Zimmerli; Edouard Battegay; Daniel Franzen Journal: BMJ Open Date: 2015-01-28 Impact factor: 2.692